Design Therapeutics (DSGN) Competitor Comparison
We are evaluating the key criteria listed to compare Design Therapeutics (DSGN) against its competitors in the Biotechnology industry.
Market Capitalization
237 / 368Gross Profits
195 / 278Total Revenue
0 / 300EBITDA
181 / 337Free Cashflow
180 / 352Quick Ratio
18 / 357Earnings per Share
120 / 359Dividend yield
0 / 6Total Cash
116 / 358Performance 3 years
196 / 368Performance 5 years
255 / 368Performance 10 years
224 / 368Linearity 3 years
164 / 368Linearity 5 years
229 / 368Linearity 10 years
201 / 368Total Rank
309 / 368Dividend Rank
108 / 368Valuation Rank
365 / 368Piotroski Rank
107 / 368Muliplier Rank
329 / 368Linearity 10 years - DSGN ranking 201 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.